NCT04101214

Brief Summary

Hypothesis: Dry needling in lower limbs produces a change in function (assessed by the 6 minute walk test, timed up and go, 10 meter walk test and unified scale for Parkinson's disease) and muscle tone (assessed by tonometry and the modified of Modified Ashworth scale(MMAS)) in patients with Parkinson's disease. The main objective of this study is to analyze the effect of dry needling on function and muscle tone in subjects with Parkinson disease. The secondary objective is to analyze the longterm effects of dry needling on function and muscle tone in subjects with Parkinson disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2019

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

January 13, 2020

Status Verified

January 1, 2020

Enrollment Period

2 months

First QC Date

September 20, 2019

Last Update Submit

January 10, 2020

Conditions

Keywords

Dry needlingParkinson Diseasemyofascial trigger point

Outcome Measures

Primary Outcomes (3)

  • 6 minute walk test

    It measures the maximum distance that the subject is able to travel in 6 minutes. It allows to obtain the speed of walking.

    Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up (at 1 week after intervention)

  • Timed up and go test

    It measures patient mobility. The patient should get up from a chair with armrests, walk three meters, turn on himself, step back three meters and sit back down. If the patient takes less than 10s, it is considered normal mobility and more than 20s reduced mobility

    Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up (at 1 week after intervention)

  • 10 meter walk test

    It used to assess walking speed in meters/second (m/s) over a short distance

    Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up (at 1 week after intervention)

Secondary Outcomes (3)

  • Modified Modified Ashworth score

    Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up (at 1 week after intervention)

  • Tonometry (measurement of muscle tone with a device)

    Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up (at 1 week after intervention)

  • Unified Parkinson's Disease Rating Scale

    Change between baseline (immediately before intervention) and follow-up at 1 week after intervention

Study Arms (2)

Dry needling

EXPERIMENTAL

One session of dry needling technique will be applied by a physiotherapist specialized in the technique. Dry needling technique will be performed in the muscle of the lower limb whose MMAS score is \>1 by locating a sensitive point within a taut band. After that, a thin needle (0,32x40mm) is introduced directly into those muscle that present spasticity, decide by the clinician expert.

Other: Dry needling

Sham Dry needling

SHAM COMPARATOR

A physiotherapist specialized in dry needling technique will use a sham needle in order to simulate the active intervention. Sham acupuncture uses non-penetrating needles.The palpation and evaluation of the spastic muscle will be exactly the same that in the active group.

Other: Sham dry Needling

Interventions

Dry needling into spastic muscle

Also known as: DNHS technique
Dry needling

Sham dry needling into spastic muscle

Sham Dry needling

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with Parkinson by a neurologist
  • Age: 50 - 90 years
  • Presence of Hypertonia according to: MMAS score \> 1 during movement of ankle dorsiflexion or knee flexion and extension

You may not qualify if:

  • Degenerative diseases that may affect the results.
  • Presence of fixed contractures.
  • Fear of needles
  • No tolerance to pain caused by dry needling
  • No commitment to continuity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asociación de Parkinson de Aragón

Zaragoza, 50015, Spain

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Elisabeth Bravo, Phd

    University of Castilla-La Mancha

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Masking is with sham dry needling, simulating to insert the needle, so no real masking 100%
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2019

First Posted

September 24, 2019

Study Start

October 1, 2019

Primary Completion

December 5, 2019

Study Completion

December 31, 2019

Last Updated

January 13, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations